- Home
- AMLX vs MUX Comparison
AMLX vs MUX Comparison
Compare AMLX & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- MUX
- Stock Information
- Founded
- AMLX 2014
- MUX 1979
- Country
- AMLX United States
- MUX Canada
- Employees
- AMLX N/A
- MUX N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- MUX Precious Metals
- Sector
- AMLX Health Care
- MUX Basic Materials
- Exchange
- AMLX Nasdaq
- MUX Nasdaq
- Market Cap
- AMLX 749.9M
- MUX 579.8M
- IPO Year
- AMLX 2022
- MUX N/A
- Fundamental
- Price
- AMLX $11.65
- MUX $13.81
- Analyst Decision
- AMLX Strong Buy
- MUX Strong Buy
- Analyst Count
- AMLX 7
- MUX 2
- Target Price
- AMLX $12.29
- MUX $16.00
- AVG Volume (30 Days)
- AMLX 1.9M
- MUX 1.5M
- Earning Date
- AMLX 11-06-2025
- MUX 11-04-2025
- Dividend Yield
- AMLX N/A
- MUX N/A
- EPS Growth
- AMLX N/A
- MUX N/A
- EPS
- AMLX N/A
- MUX N/A
- Revenue
- AMLX N/A
- MUX $168,169,000.00
- Revenue This Year
- AMLX N/A
- MUX N/A
- Revenue Next Year
- AMLX N/A
- MUX $7.52
- P/E Ratio
- AMLX N/A
- MUX N/A
- Revenue Growth
- AMLX N/A
- MUX N/A
- 52 Week Low
- AMLX $2.47
- MUX $6.38
- 52 Week High
- AMLX $12.25
- MUX $14.29
- Technical
- Relative Strength Index (RSI)
- AMLX 76.42
- MUX 71.19
- Support Level
- AMLX $9.15
- MUX $13.28
- Resistance Level
- AMLX $12.25
- MUX $14.04
- Average True Range (ATR)
- AMLX 0.59
- MUX 0.56
- MACD
- AMLX 0.22
- MUX 0.17
- Stochastic Oscillator
- AMLX 84.13
- MUX 86.32
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.